Basket and Umbrella Trial Execution: Operational Complexity, Managed

Basket trials and umbrella trials represent some of the most operationally complex designs in modern oncology development. Both move beyond the traditional single-indication, single-arm model and introduce coordination challenges that require a CRO with genuine experience managing multi-arm complexity.

Sitero supports basket and umbrella trial execution with an integrated operational and technology model designed for the demands these designs create.

Basket Trials: One Therapy, Multiple Tumor Types

A basket trial evaluates a single investigational therapy across multiple tumor types, typically selected based on a shared genomic alteration or molecular target. The operational challenge is running what is effectively multiple parallel sub-studies under one protocol umbrella — with shared operational infrastructure but distinct enrollment, eligibility, and endpoint management for each tumor type cohort.

Site selection becomes more complex: each cohort requires sites with the relevant patient population for that tumor type. Biomarker screening must be coordinated across tumor types, each with potentially different testing requirements. Sitero’s model treats each tumor type cohort as a distinct operational unit within the broader study framework — with dedicated site management, cohort-specific startup, and EDC configurations that support both cohort-level and study-level data review.

Umbrella Trials: Multiple Therapies, One Indication

An umbrella trial tests multiple investigational therapies — or therapy combinations — within a single tumor type, typically stratified by molecular subtype. The operational challenge shifts to supply and randomization: multiple agents, potentially from different manufacturers, allocated to patients based on biomarker-driven sub-study assignment.

Sitero’s RTSM manages multi-arm supply allocation in umbrella designs, including arm-specific inventory management, adaptive resupply logic, and audit-ready dispensing records for each sub-study. When interim data triggers arm closures or expansions, the RTSM executes those changes with the documentation trail required for regulatory review.

Cross-Arm Safety Oversight

Both basket and umbrella designs generate safety data that must be assessed at the cohort/arm level and at the study level. A safety signal in one arm or tumor type cohort has implications for the full program. Sitero’s pharmacovigilance team manages cross-arm safety oversight, ensuring aggregate safety assessment reflects the full study dataset while maintaining arm-specific case processing where required by protocol.

Data Management for Complex Multi-Arm Structures

The final analysis dataset for a basket or umbrella trial involves multiple endpoint sets, cohort-specific analysis populations, and potentially different statistical analysis plans by sub-study. Sitero’s biometrics team designs data management and statistical specifications that accommodate this complexity from the start, reducing the data remediation work that drives extended closeout timelines.